Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GDA | Q9Y2T3 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.45 |
| ▸ | PDE4A | P27815 | 4/20 | 0.45 |
| ▸ | PDE4B | Q07343 | 4/20 | 0.45 |
| ▸ | PDE4C | Q08493 | 4/20 | 0.45 |
| ▸ | PDE4D | Q08499 | 4/20 | 0.45 |
| ▸ | ACHE | P22303 | 2/20 | 0.40 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 7-Methylxanthine SCHEMBL31071477 | 1.00 | GDA (1.00) | GDACYP3A4PMP22BLMALDH1A1 | |
| 7-Methylxanthine SCHEMBL31071476 | 1.00 | GDA (1.00) | GDACYP3A4PMP22BLMALDH1A1 | |
| 7-Methylxanthine SCHEMBL28591758 | 1.00 | GDA (1.00) | GDACYP3A4PMP22BLMALDH1A1 | |
| 7-Methylxanthine SCHEMBL2466924 | 0.87 | GDA (0.77) | GDACYP3A4PMP22BLMALDH1A1 | |
| Paraxanthine SCHEMBL28735832 | 0.87 | CYP3A4 (0.79) | GDACYP3A4PMP22BLMALDH1A1 | |
| 7-Methylxanthine SCHEMBL1495254 | 0.87 | GDA (0.77) | GDACYP3A4PMP22BLMALDH1A1 | |
| 7-Methylxanthine SCHEMBL15670710 | 0.86 | GDA (0.74) | GDACYP3A4PMP22BLMALDH1A1 | |
| Theobromine SCHEMBL28735869 | 0.86 | CYP3A4 (0.77) | GDACYP3A4PMP22BLMALDH1A1 | |
| 7-Methylxanthine SCHEMBL14880777 | 0.84 | GDA (0.70) | GDACYP3A4PMP22BLMALDH1A1 | |
| Caffeine SCHEMBL6551434 | 0.79 | CYP3A4 (0.64) | GDACYP3A4PMP22BLMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 917 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116850183-B | Methods and pharmaceutical compositions for treating myopia | GRAND PHARMA (CHINA) Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| WO-2026089413-A1 | NUCLEATING AGENT FOR BIODEGRADABLE RESIN AND BIODEGRADABLE RESIN COMPOSITION COMPRISING SAME | 씨제이제일제당(주) | 2026-04-30 | — | — | WO | claimed |
| EP-4680228-A2 | OPHTHALMIC CREAM FORMULATIONS AND THEIR USES | Glaukos Corporation (US) | 2026-01-21 | — | — | EP | claimed |
| EP-4648778-A1 | METHOD FOR TREATING NETOSIS-MEDIATED DISEASES | National Health Research Institutes (TW) | 2025-11-19 | — | — | EP | claimed |
| US-12448633-B2 | Bacterial N-demthylases as biocatalysts for the production of methylxanthines | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2025-10-21 | — | — | US | claimed |
| CN-119890419-A | Solid electrolyte and preparation method thereof | 深圳欣界能源科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| WO-2025064610-A1 | ENGINEERED MICROBIAL MONOCULTURES AND BIOCATALYTIC METHODS FOR PRODUCING PURINE ALKALOIDS, INCLUDING 7-METHYLXANTHINE | BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIVERSITY (US) | 2025-03-27 | — | — | WO | claimed |
| CN-119548497-A | Method for treating myopia by using vinpocetine | 温州医科大学附属眼视光医院 | 2025-03-04 | — | — | CN | claimed |
| WO-2025026900-A1 | COMPOUNDS FOR THE TREATMENT OR PREVENTION OF GOUT | UNIVERSITAT DE LES ILLES BALEARS (ES) | 2025-02-06 | — | — | WO | claimed |
| EP-4497439-A1 | COMPOUNDS FOR THE TREATMENT OR PREVENTION OF GOUT | Universitat de les Illes Balears (ES) | 2025-01-29 | — | — | EP | claimed |
| WO-2001079837-A1 | METHYLXANTHINES IN THE DIAGNOSIS AND TREATMENT OF AUTISTIC DISORDER | REPLIGEN CORPORATION (US) | 2001-10-25 | — | — | WO | claimed |
| EP-1055727-A2 | Cloning of an N-methyltransferase involved in caffeine biosynthesis | Mitsui Chemicals, Inc. (JP) | 2000-11-29 | — | — | EP | claimed |
| WO-1998030900-A2 | SCREENING METHOD FOR COMPOUNDS ACTIVE IN TREATING MYOPIA AND HYPERMETROPIA | KLAUS TRIER APS (DK) | 1998-07-16 | — | — | WO | claimed |
| EP-0485156-B1 | Methods and compounds for labeling DNA with xanthine and lower alkyl substituted xanthine derivatives and reagents for the in situ detection of chromosomes | AMOCO CORP (US) | 1997-03-05 | — | — | EP | claimed |
| US-5550041-A | PRODUCING 3-METHYL-7-ALKYLXANTHINE BY CULTIVATING PSEUDOMONAS TRANSFORMED TO PRODUCE CAFFEINE DEMETHYLASE IN NUTRIENT MEDIUM CONTAINING 1,3-DIMETHYL-7-ALKYLXANTHINE | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1996-08-27 | — | — | US | claimed |
| US-5512433-A | XANTHINE OR ALKYL SUBSTITUTED XANTHINE DERIVATIVE LABELS ARE CONVALENTLY LINKED TO DNA SEQUENCES, XANTHINE LINKED DNA REAGENTS ARE HYBRIDIZED WITH CHROMOSOME OR SPECIFIC REGIONS OF CHROMOSOME, BINDING IS DETECTED BY IMMUNOLOGICAL TECHNIQUE | VYSIS, INC. (US) | 1996-04-30 | — | — | US | claimed |
| EP-0662834-A4 | NOVEL EPOXIDE-CONTAINING COMPOUNDS. | CELL THERAPEUTICS INC (US) | 1996-04-17 | — | — | EP | claimed |
| EP-0662834-A1 | NOVEL EPOXIDE-CONTAINING COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1995-07-19 | — | — | EP | claimed |
| WO-1994006431-A1 | NOVEL EPOXIDE-CONTAINING COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1994-03-31 | — | — | WO | claimed |
| EP-0485156-A1 | Methods and compounds for labeling DNA with xanthine and lower alkyl substituted xanthine derivatives and reagents for the in situ detection of chromosomes | AMOCO CORPORATION (US) | 1992-05-13 | — | — | EP | claimed |